Clearmind Medicine Current Debt
| CMND Stock | USD 1.49 0.09 5.70% |
As of January 7, 2025, Short and Long Term Debt is expected to decline to about 24.9 K. In addition to that, Short Term Debt is expected to decline to about 26.4 K. Clearmind Medicine's financial risk is the risk to Clearmind Medicine stockholders that is caused by an increase in debt.
Debt Ratio | First Reported 2010-12-31 | Previous Quarter 0.0 | Current Value 0.0 | Quarterly Volatility 0.0 |
Given that Clearmind Medicine's debt-to-equity ratio measures a Company's obligations relative to the value of its net assets, it is usually used by traders to estimate the extent to which Clearmind Medicine is acquiring new debt as a mechanism of leveraging its assets. A high debt-to-equity ratio is generally associated with increased risk, implying that it has been aggressive in financing its growth with debt. Another way to look at debt-to-equity ratios is to compare the overall debt load of Clearmind Medicine to its assets or equity, showing how much of the company assets belong to shareholders vs. creditors. If shareholders own more assets, Clearmind Medicine is said to be less leveraged. If creditors hold a majority of Clearmind Medicine's assets, the Company is said to be highly leveraged.
The current year's Total Current Liabilities is expected to grow to about 4.4 M. The current year's Liabilities And Stockholders Equity is expected to grow to about 5.2 MClearmind |
Clearmind Medicine Financial Rating
Clearmind Medicine Common financial ratings play a critical role in determining how much Clearmind Medicine have to pay to access credit markets, i.e., the amount of interest on their issued debt. The threshold between investment-grade and speculative-grade ratings has important market implications for Clearmind Medicine's borrowing costs.| Piotroski F Score | 2 | Frail | View |
| Beneish M Score | (8.11) | Unlikely Manipulator | View |
Clearmind Medicine Common Debt to Cash Allocation
Many companies such as Clearmind Medicine, eventually find out that there is only so much market out there to be conquered, and adding the next product or service is only half as profitable per unit as their current endeavors. Eventually, the company will reach a point where cash flows are strong, and extra cash is available but not fully utilized. In this case, the company may start buying back its stock from the public or issue more dividends.
Clearmind Medicine Common currently holds 3.61 M in liabilities. Clearmind Medicine Common has a current ratio of 0.03, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Clearmind Medicine's use of debt, we should always consider it together with its cash and equity.Clearmind Medicine Total Assets Over Time
Clearmind Medicine Assets Financed by Debt
Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Clearmind Medicine's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Clearmind Medicine, which in turn will lower the firm's financial flexibility.Clearmind Short Long Term Debt
Short Long Term Debt |
|
Understaning Clearmind Medicine Use of Financial Leverage
Clearmind Medicine's financial leverage ratio helps determine the effect of debt on the overall profitability of the company. It measures Clearmind Medicine's total debt position, including all outstanding debt obligations, and compares it with Clearmind Medicine's equity. Financial leverage can amplify the potential profits to Clearmind Medicine's owners, but it also increases the potential losses and risk of financial distress, including bankruptcy, if Clearmind Medicine is unable to cover its debt costs.
| Last Reported | Projected for Next Year | ||
| Short and Long Term Debt | 35.7 K | 24.9 K | |
| Short Term Debt | 32.4 K | 26.4 K | |
| Net Debt | -3.5 M | -3.4 M | |
| Short and Long Term Debt Total | 47.2 K | 41.9 K | |
| Net Debt To EBITDA | 0.52 | 0.49 | |
| Interest Debt Per Share | 0.41 | 0.36 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| BTC | Bitcoin | |
| TRX | TRON | |
| BNB | Binance Coin |
Check out the analysis of Clearmind Medicine Fundamentals Over Time. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Clearmind Medicine. If investors know Clearmind will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Clearmind Medicine listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Clearmind Medicine Common is measured differently than its book value, which is the value of Clearmind that is recorded on the company's balance sheet. Investors also form their own opinion of Clearmind Medicine's value that differs from its market value or its book value, called intrinsic value, which is Clearmind Medicine's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Clearmind Medicine's market value can be influenced by many factors that don't directly affect Clearmind Medicine's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Clearmind Medicine's value and its price as these two are different measures arrived at by different means. Investors typically determine if Clearmind Medicine is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Clearmind Medicine's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
What is Financial Leverage?
Financial leverage is the use of borrowed money (debt) to finance the purchase of assets with the expectation that the income or capital gain from the new asset will exceed the cost of borrowing. In most cases, the debt provider will limit how much risk it is ready to take and indicate a limit on the extent of the leverage it will allow. In the case of asset-backed lending, the financial provider uses the assets as collateral until the borrower repays the loan. In the case of a cash flow loan, the general creditworthiness of the company is used to back the loan. The concept of leverage is common in the business world. It is mostly used to boost the returns on equity capital of a company, especially when the business is unable to increase its operating efficiency and returns on total investment. Because earnings on borrowing are higher than the interest payable on debt, the company's total earnings will increase, ultimately boosting stockholders' profits.Leverage and Capital Costs
The debt to equity ratio plays a role in the working average cost of capital (WACC). The overall interest on debt represents the break-even point that must be obtained to profitability in a given venture. Thus, WACC is essentially the average interest an organization owes on the capital it has borrowed for leverage. Let's say equity represents 60% of borrowed capital, and debt is 40%. This results in a financial leverage calculation of 40/60, or 0.6667. The organization owes 10% on all equity and 5% on all debt. That means that the weighted average cost of capital is (.4)(5) + (.6)(10) - or 8%. For every $10,000 borrowed, this organization will owe $800 in interest. Profit must be higher than 8% on the project to offset the cost of interest and justify this leverage.Benefits of Financial Leverage
Leverage provides the following benefits for companies:- Leverage is an essential tool a company's management can use to make the best financing and investment decisions.
- It provides a variety of financing sources by which the firm can achieve its target earnings.
- Leverage is also an essential technique in investing as it helps companies set a threshold for the expansion of business operations. For example, it can be used to recommend restrictions on business expansion once the projected return on additional investment is lower than the cost of debt.